世界のRNAi療法市場の成長（現状と展望） 2023-2029

Global RNAi Therapy Market Growth (Status and Outlook) 2023-2029

RNAi Therapyの世界市場規模は、2022年の100万米ドルから2029年には100万米ドルになると予測されており、2023年から2029年までのCAGRは%であると予想されています。 RNAi Therapyの米国市場は、2023年から2029年... もっと見る

出版社	出版年月	電子版価格	ページ数	言語
LP Information LPインフォメーション	2023年5月16日	US$3,660 シングルユーザライセンスライセンス・価格情報注文方法はこちら	86	英語

目次
図表リスト

サマリー

RNAi Therapyの世界市場規模は、2022年の100万米ドルから2029年には100万米ドルになると予測されており、2023年から2029年までのCAGRは%であると予想されています。
RNAi Therapyの米国市場は、2023年から2029年までのCAGR %で、2022年の百万米ドルから2029年には百万米ドルに増加すると予測されています。
RNAi Therapyの中国市場は、2023年から2029年までの年平均成長率で、2022年の100万米ドルから2029年には100万米ドルに増加すると推定されます。
RNAi Therapyのヨーロッパ市場は、2023年から2029年にかけてのCAGR %で、2022年の百万米ドルから2029年には百万米ドルに増加すると推定されます。
RNAi Therapyの世界的な主要企業は、Alnylam、Sarepta Therapeutics、Alnylam Pharmaceuticals、Moderna、Sanofi、Arcturus Therapeutics、Silence、Sirnaomicsなど。収益面では、世界の2大企業が2022年にほぼ％のシェアを占めています。
LPI（エルピーアイ）の最新リサーチレポート「RNAi Therapy Industry Forecast」は、過去の売上から2022年の世界のRNAi Therapyの総売上を検証し、2023年から2029年のRNAi Therapyの売上予測について地域や市場分野ごとに包括的な分析を提供しています。RNAi Therapyの売上を地域別、市場分野別、サブセクター別に分類し、世界のRNAi Therapy産業の詳細な分析を百万米ドル単位で提供します。
本インサイトレポートでは、世界のRNAi Therapyの状況を包括的に分析し、製品区分、会社設立、収益、市場シェア、最新開発、M&A活動に関する主要動向を明らかにしています。また、RNAi療法のポートフォリオと能力、市場参入戦略、市場での地位、地理的な足跡に焦点を当てて、主要なグローバル企業の戦略を分析し、加速する世界のRNAi療法市場におけるこれらの企業の独自の地位をより良く理解することができます。
本インサイトレポートでは、RNAi療法の世界的な見通しを形成する主要な市場動向、推進要因、影響要因を評価し、タイプ別、アプリケーション別、地域別、市場規模別に予測を行い、新たな機会のポケットを明らかにします。何百ものボトムアップの定性的・定量的な市場インプットに基づく透明性の高い手法により、本調査予測は、世界のRNAi療法の現状と将来の軌道について非常にニュアンスのある見方を提供します。
本レポートでは、RNAi Therapy市場の製品タイプ、用途、主要プレイヤー、主要地域、国別の包括的な概要、市場シェア、成長機会について紹介します。
市場のセグメンテーション
タイプ別セグメンテーション
低分子干渉性リボ核酸(SiRNA)
マイクロRNA（MiRNA）
アプリケーション別セグメンテーション
オンコロジー
循環器領域
その他
また、本レポートでは、地域別に市場を分割しています：
米州
アメリカ
カナダ
メキシコ
ブラジル
APAC
中国
日本
韓国
東南アジア
インド
オーストラリア
欧州
ドイツ
フランス
イギリス
イタリア
ロシア
中近東・アフリカ
エジプト
南アフリカ
イスラエル
トルコ
GCC諸国
以下の企業は、主要な専門家から収集した情報、企業のカバレッジ、製品ポートフォリオ、市場浸透度を分析した上で選定されています。
アルニラム
サレプタ・セラピューティクス
アルナイラム・ファーマシューティカルズ
モデナ
サノフィ
アークトゥルス・セラピューティック
サイレンス
サーナオミクス

ページTOPに戻る

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global RNAi Therapy Market Size 2018-2029
2.1.2 RNAi Therapy Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 RNAi Therapy Segment by Type
2.2.1 Small Molecule Interfering Ribonucleic Acid (SiRNA)
2.2.2 Microrna (MiRNA)
2.3 RNAi Therapy Market Size by Type
2.3.1 RNAi Therapy Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global RNAi Therapy Market Size Market Share by Type (2018-2023)
2.4 RNAi Therapy Segment by Application
2.4.1 Oncology
2.4.2 Cardiology
2.4.3 Others
2.5 RNAi Therapy Market Size by Application
2.5.1 RNAi Therapy Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global RNAi Therapy Market Size Market Share by Application (2018-2023)
3 RNAi Therapy Market Size by Player
3.1 RNAi Therapy Market Size Market Share by Players
3.1.1 Global RNAi Therapy Revenue by Players (2018-2023)
3.1.2 Global RNAi Therapy Revenue Market Share by Players (2018-2023)
3.2 Global RNAi Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 RNAi Therapy by Regions
4.1 RNAi Therapy Market Size by Regions (2018-2023)
4.2 Americas RNAi Therapy Market Size Growth (2018-2023)
4.3 APAC RNAi Therapy Market Size Growth (2018-2023)
4.4 Europe RNAi Therapy Market Size Growth (2018-2023)
4.5 Middle East & Africa RNAi Therapy Market Size Growth (2018-2023)
5 Americas
5.1 Americas RNAi Therapy Market Size by Country (2018-2023)
5.2 Americas RNAi Therapy Market Size by Type (2018-2023)
5.3 Americas RNAi Therapy Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC RNAi Therapy Market Size by Region (2018-2023)
6.2 APAC RNAi Therapy Market Size by Type (2018-2023)
6.3 APAC RNAi Therapy Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe RNAi Therapy by Country (2018-2023)
7.2 Europe RNAi Therapy Market Size by Type (2018-2023)
7.3 Europe RNAi Therapy Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa RNAi Therapy by Region (2018-2023)
8.2 Middle East & Africa RNAi Therapy Market Size by Type (2018-2023)
8.3 Middle East & Africa RNAi Therapy Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global RNAi Therapy Market Forecast
10.1 Global RNAi Therapy Forecast by Regions (2024-2029)
10.1.1 Global RNAi Therapy Forecast by Regions (2024-2029)
10.1.2 Americas RNAi Therapy Forecast
10.1.3 APAC RNAi Therapy Forecast
10.1.4 Europe RNAi Therapy Forecast
10.1.5 Middle East & Africa RNAi Therapy Forecast
10.2 Americas RNAi Therapy Forecast by Country (2024-2029)
10.2.1 United States RNAi Therapy Market Forecast
10.2.2 Canada RNAi Therapy Market Forecast
10.2.3 Mexico RNAi Therapy Market Forecast
10.2.4 Brazil RNAi Therapy Market Forecast
10.3 APAC RNAi Therapy Forecast by Region (2024-2029)
10.3.1 China RNAi Therapy Market Forecast
10.3.2 Japan RNAi Therapy Market Forecast
10.3.3 Korea RNAi Therapy Market Forecast
10.3.4 Southeast Asia RNAi Therapy Market Forecast
10.3.5 India RNAi Therapy Market Forecast
10.3.6 Australia RNAi Therapy Market Forecast
10.4 Europe RNAi Therapy Forecast by Country (2024-2029)
10.4.1 Germany RNAi Therapy Market Forecast
10.4.2 France RNAi Therapy Market Forecast
10.4.3 UK RNAi Therapy Market Forecast
10.4.4 Italy RNAi Therapy Market Forecast
10.4.5 Russia RNAi Therapy Market Forecast
10.5 Middle East & Africa RNAi Therapy Forecast by Region (2024-2029)
10.5.1 Egypt RNAi Therapy Market Forecast
10.5.2 South Africa RNAi Therapy Market Forecast
10.5.3 Israel RNAi Therapy Market Forecast
10.5.4 Turkey RNAi Therapy Market Forecast
10.5.5 GCC Countries RNAi Therapy Market Forecast
10.6 Global RNAi Therapy Forecast by Type (2024-2029)
10.7 Global RNAi Therapy Forecast by Application (2024-2029)

11 Key Players Analysis
11.1 Alnylam
11.1.1 Alnylam Company Information
11.1.2 Alnylam RNAi Therapy Product Offered
11.1.3 Alnylam RNAi Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Alnylam Main Business Overview
11.1.5 Alnylam Latest Developments
11.2 Sarepta Therapeutics
11.2.1 Sarepta Therapeutics Company Information
11.2.2 Sarepta Therapeutics RNAi Therapy Product Offered
11.2.3 Sarepta Therapeutics RNAi Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Sarepta Therapeutics Main Business Overview
11.2.5 Sarepta Therapeutics Latest Developments
11.3 Alnylam Pharmaceuticals
11.3.1 Alnylam Pharmaceuticals Company Information
11.3.2 Alnylam Pharmaceuticals RNAi Therapy Product Offered
11.3.3 Alnylam Pharmaceuticals RNAi Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Alnylam Pharmaceuticals Main Business Overview
11.3.5 Alnylam Pharmaceuticals Latest Developments
11.4 Moderna
11.4.1 Moderna Company Information
11.4.2 Moderna RNAi Therapy Product Offered
11.4.3 Moderna RNAi Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Moderna Main Business Overview
11.4.5 Moderna Latest Developments
11.5 Sanofi
11.5.1 Sanofi Company Information
11.5.2 Sanofi RNAi Therapy Product Offered
11.5.3 Sanofi RNAi Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Sanofi Main Business Overview
11.5.5 Sanofi Latest Developments
11.6 Arcturus Therapeutics
11.6.1 Arcturus Therapeutics Company Information
11.6.2 Arcturus Therapeutics RNAi Therapy Product Offered
11.6.3 Arcturus Therapeutics RNAi Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Arcturus Therapeutics Main Business Overview
11.6.5 Arcturus Therapeutics Latest Developments
11.7 Silence
11.7.1 Silence Company Information
11.7.2 Silence RNAi Therapy Product Offered
11.7.3 Silence RNAi Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Silence Main Business Overview
11.7.5 Silence Latest Developments
11.8 Sirnaomics
11.8.1 Sirnaomics Company Information
11.8.2 Sirnaomics RNAi Therapy Product Offered
11.8.3 Sirnaomics RNAi Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Sirnaomics Main Business Overview
11.8.5 Sirnaomics Latest Developments
12 Research Findings and Conclusion

ページTOPに戻る

図表リスト

List of Tables
Table 1. RNAi Therapy Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Small Molecule Interfering Ribonucleic Acid (SiRNA)
Table 3. Major Players of Microrna (MiRNA)
Table 4. RNAi Therapy Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global RNAi Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global RNAi Therapy Market Size Market Share by Type (2018-2023)
Table 7. RNAi Therapy Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global RNAi Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global RNAi Therapy Market Size Market Share by Application (2018-2023)
Table 10. Global RNAi Therapy Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global RNAi Therapy Revenue Market Share by Player (2018-2023)
Table 12. RNAi Therapy Key Players Head office and Products Offered
Table 13. RNAi Therapy Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global RNAi Therapy Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global RNAi Therapy Market Size Market Share by Regions (2018-2023)
Table 18. Global RNAi Therapy Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global RNAi Therapy Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas RNAi Therapy Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas RNAi Therapy Market Size Market Share by Country (2018-2023)
Table 22. Americas RNAi Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas RNAi Therapy Market Size Market Share by Type (2018-2023)
Table 24. Americas RNAi Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas RNAi Therapy Market Size Market Share by Application (2018-2023)
Table 26. APAC RNAi Therapy Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC RNAi Therapy Market Size Market Share by Region (2018-2023)
Table 28. APAC RNAi Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC RNAi Therapy Market Size Market Share by Type (2018-2023)
Table 30. APAC RNAi Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC RNAi Therapy Market Size Market Share by Application (2018-2023)
Table 32. Europe RNAi Therapy Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe RNAi Therapy Market Size Market Share by Country (2018-2023)
Table 34. Europe RNAi Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe RNAi Therapy Market Size Market Share by Type (2018-2023)
Table 36. Europe RNAi Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe RNAi Therapy Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa RNAi Therapy Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa RNAi Therapy Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa RNAi Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa RNAi Therapy Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa RNAi Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa RNAi Therapy Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of RNAi Therapy
Table 45. Key Market Challenges & Risks of RNAi Therapy
Table 46. Key Industry Trends of RNAi Therapy
Table 47. Global RNAi Therapy Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global RNAi Therapy Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global RNAi Therapy Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global RNAi Therapy Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. Alnylam Details, Company Type, RNAi Therapy Area Served and Its Competitors
Table 52. Alnylam RNAi Therapy Product Offered
Table 53. Alnylam RNAi Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. Alnylam Main Business
Table 55. Alnylam Latest Developments
Table 56. Sarepta Therapeutics Details, Company Type, RNAi Therapy Area Served and Its Competitors
Table 57. Sarepta Therapeutics RNAi Therapy Product Offered
Table 58. Sarepta Therapeutics Main Business
Table 59. Sarepta Therapeutics RNAi Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. Sarepta Therapeutics Latest Developments
Table 61. Alnylam Pharmaceuticals Details, Company Type, RNAi Therapy Area Served and Its Competitors
Table 62. Alnylam Pharmaceuticals RNAi Therapy Product Offered
Table 63. Alnylam Pharmaceuticals Main Business
Table 64. Alnylam Pharmaceuticals RNAi Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Alnylam Pharmaceuticals Latest Developments
Table 66. Moderna Details, Company Type, RNAi Therapy Area Served and Its Competitors
Table 67. Moderna RNAi Therapy Product Offered
Table 68. Moderna Main Business
Table 69. Moderna RNAi Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. Moderna Latest Developments
Table 71. Sanofi Details, Company Type, RNAi Therapy Area Served and Its Competitors
Table 72. Sanofi RNAi Therapy Product Offered
Table 73. Sanofi Main Business
Table 74. Sanofi RNAi Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. Sanofi Latest Developments
Table 76. Arcturus Therapeutics Details, Company Type, RNAi Therapy Area Served and Its Competitors
Table 77. Arcturus Therapeutics RNAi Therapy Product Offered
Table 78. Arcturus Therapeutics Main Business
Table 79. Arcturus Therapeutics RNAi Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. Arcturus Therapeutics Latest Developments
Table 81. Silence Details, Company Type, RNAi Therapy Area Served and Its Competitors
Table 82. Silence RNAi Therapy Product Offered
Table 83. Silence Main Business
Table 84. Silence RNAi Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 85. Silence Latest Developments
Table 86. Sirnaomics Details, Company Type, RNAi Therapy Area Served and Its Competitors
Table 87. Sirnaomics RNAi Therapy Product Offered
Table 88. Sirnaomics Main Business
Table 89. Sirnaomics RNAi Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 90. Sirnaomics Latest Developments
List of Figures
Figure 1. RNAi Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global RNAi Therapy Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. RNAi Therapy Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. RNAi Therapy Sales Market Share by Country/Region (2022)
Figure 8. RNAi Therapy Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global RNAi Therapy Market Size Market Share by Type in 2022
Figure 10. RNAi Therapy in Oncology
Figure 11. Global RNAi Therapy Market: Oncology (2018-2023) & ($ Millions)
Figure 12. RNAi Therapy in Cardiology
Figure 13. Global RNAi Therapy Market: Cardiology (2018-2023) & ($ Millions)
Figure 14. RNAi Therapy in Others
Figure 15. Global RNAi Therapy Market: Others (2018-2023) & ($ Millions)
Figure 16. Global RNAi Therapy Market Size Market Share by Application in 2022
Figure 17. Global RNAi Therapy Revenue Market Share by Player in 2022
Figure 18. Global RNAi Therapy Market Size Market Share by Regions (2018-2023)
Figure 19. Americas RNAi Therapy Market Size 2018-2023 ($ Millions)
Figure 20. APAC RNAi Therapy Market Size 2018-2023 ($ Millions)
Figure 21. Europe RNAi Therapy Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa RNAi Therapy Market Size 2018-2023 ($ Millions)
Figure 23. Americas RNAi Therapy Value Market Share by Country in 2022
Figure 24. United States RNAi Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada RNAi Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico RNAi Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil RNAi Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC RNAi Therapy Market Size Market Share by Region in 2022
Figure 29. APAC RNAi Therapy Market Size Market Share by Type in 2022
Figure 30. APAC RNAi Therapy Market Size Market Share by Application in 2022
Figure 31. China RNAi Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan RNAi Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea RNAi Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia RNAi Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 35. India RNAi Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia RNAi Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe RNAi Therapy Market Size Market Share by Country in 2022
Figure 38. Europe RNAi Therapy Market Size Market Share by Type (2018-2023)
Figure 39. Europe RNAi Therapy Market Size Market Share by Application (2018-2023)
Figure 40. Germany RNAi Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 41. France RNAi Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK RNAi Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy RNAi Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia RNAi Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa RNAi Therapy Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa RNAi Therapy Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa RNAi Therapy Market Size Market Share by Application (2018-2023)
Figure 48. Egypt RNAi Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa RNAi Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel RNAi Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey RNAi Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country RNAi Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas RNAi Therapy Market Size 2024-2029 ($ Millions)
Figure 54. APAC RNAi Therapy Market Size 2024-2029 ($ Millions)
Figure 55. Europe RNAi Therapy Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa RNAi Therapy Market Size 2024-2029 ($ Millions)
Figure 57. United States RNAi Therapy Market Size 2024-2029 ($ Millions)
Figure 58. Canada RNAi Therapy Market Size 2024-2029 ($ Millions)
Figure 59. Mexico RNAi Therapy Market Size 2024-2029 ($ Millions)
Figure 60. Brazil RNAi Therapy Market Size 2024-2029 ($ Millions)
Figure 61. China RNAi Therapy Market Size 2024-2029 ($ Millions)
Figure 62. Japan RNAi Therapy Market Size 2024-2029 ($ Millions)
Figure 63. Korea RNAi Therapy Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia RNAi Therapy Market Size 2024-2029 ($ Millions)
Figure 65. India RNAi Therapy Market Size 2024-2029 ($ Millions)
Figure 66. Australia RNAi Therapy Market Size 2024-2029 ($ Millions)
Figure 67. Germany RNAi Therapy Market Size 2024-2029 ($ Millions)
Figure 68. France RNAi Therapy Market Size 2024-2029 ($ Millions)
Figure 69. UK RNAi Therapy Market Size 2024-2029 ($ Millions)
Figure 70. Italy RNAi Therapy Market Size 2024-2029 ($ Millions)
Figure 71. Russia RNAi Therapy Market Size 2024-2029 ($ Millions)
Figure 72. Spain RNAi Therapy Market Size 2024-2029 ($ Millions)
Figure 73. Egypt RNAi Therapy Market Size 2024-2029 ($ Millions)
Figure 74. South Africa RNAi Therapy Market Size 2024-2029 ($ Millions)
Figure 75. Israel RNAi Therapy Market Size 2024-2029 ($ Millions)
Figure 76. Turkey RNAi Therapy Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries RNAi Therapy Market Size 2024-2029 ($ Millions)
Figure 78. Global RNAi Therapy Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global RNAi Therapy Market Size Market Share Forecast by Application (2024-2029)

ページTOPに戻る

Table of Contents
List of Tables/Graphs

Summary

The global RNAi Therapy market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for RNAi Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for RNAi Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for RNAi Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key RNAi Therapy players cover Alnylam, Sarepta Therapeutics, Alnylam Pharmaceuticals, Moderna, Sanofi, Arcturus Therapeutics, Silence and Sirnaomics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)' newest research report, the “RNAi Therapy Industry Forecast” looks at past sales and reviews total world RNAi Therapy sales in 2022, providing a comprehensive analysis by region and market sector of projected RNAi Therapy sales for 2023 through 2029. With RNAi Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world RNAi Therapy industry.
This Insight Report provides a comprehensive analysis of the global RNAi Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on RNAi Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global RNAi Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for RNAi Therapy and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global RNAi Therapy.
This report presents a comprehensive overview, market shares, and growth opportunities of RNAi Therapy market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Small Molecule Interfering Ribonucleic Acid (SiRNA)
Microrna (MiRNA)
Segmentation by application
Oncology
Cardiology
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Alnylam
Sarepta Therapeutics
Alnylam Pharmaceuticals
Moderna
Sanofi
Arcturus Therapeutics
Silence
Sirnaomics

ページTOPに戻る

List of Tables/Graphs

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（医療）の最新刊レポート

LP Information社の医療分野での最新刊レポート

本レポートと同じKEY WORD（）の最新刊レポート

本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問

LP Information社はどのような調査会社ですか?

LP Informationは通信、エネルギー、医薬をはじめとする広範な市場の調査とレポート出版を行っている調査会社です。もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

世界のRNAi療法市場の成長（現状と展望） 2023-2029

サマリー

目次

図表リスト

Summary

Table of Contents

List of Tables/Graphs

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（医療）の最新刊レポート

LP Information社の医療分野での最新刊レポート

本レポートと同じKEY WORD（）の最新刊レポート

よくあるご質問

LP Information社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?